Fennec Pharmaceuticals Inc (FENC) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.76 is considered Undervalued compared with the five-year average of 5.62. The fair price of Fennec Pharmaceuticals Inc (FENC) is between 9.62 to 11.03 according to relative valuation method. Compared to the current price of 8.20 USD , Fennec Pharmaceuticals Inc By Undervalued By 14.78%.

Relative Value

Fair Zone

9.62-11.03

Current Price：8.20

14.78%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Fennec Pharmaceuticals Inc (FENC) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Fennec Pharmaceuticals Inc (FENC) has a current Price-to-Book (P/B) ratio of -47.98. Compared to its 3-year average P/B ratio of -32.58, the current P/B ratio is approximately 47.28% higher. Relative to its 5-year average P/B ratio of -14.55, the current P/B ratio is about 229.82% higher. Fennec Pharmaceuticals Inc (FENC) has a Forward Free Cash Flow (FCF) yield of approximately -3.04%. Compared to its 3-year average FCF yield of 0.81%, the current FCF yield is approximately -475.65% lower. Relative to its 5-year average FCF yield of -2.99%, the current FCF yield is about 1.69% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for FENC competitors is 7.47, providing a benchmark for relative valuation. Fennec Pharmaceuticals Inc Corp (FENC.O) exhibits a P/S ratio of 3.76, which is -49.62% above the industry average. Given its robust revenue growth of 78.69%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of FENC increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of FENC in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is FENC currently overvalued or undervalued?

Fennec Pharmaceuticals Inc (FENC) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.76 is considered Undervalued compared with the five-year average of 5.62. The fair price of Fennec Pharmaceuticals Inc (FENC) is between 9.62 to 11.03 according to relative valuation method. Compared to the current price of 8.20 USD, Fennec Pharmaceuticals Inc is Undervalued By 14.78%.

What is Fennec Pharmaceuticals Inc (FENC) fair value?

FENC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Fennec Pharmaceuticals Inc (FENC) is between 9.62 to 11.03 according to relative valuation method.

How does FENC's valuation metrics compare to the industry average?

The average P/S ratio for FENC's competitors is 7.47, providing a benchmark for relative valuation. Fennec Pharmaceuticals Inc Corp (FENC) exhibits a P/S ratio of 3.76, which is -49.62% above the industry average. Given its robust revenue growth of 78.69%, this premium appears sustainable.

What is the current P/B ratio for Fennec Pharmaceuticals Inc (FENC) as of Mar 04 2026?

As of Mar 04 2026, Fennec Pharmaceuticals Inc (FENC) has a P/B ratio of -47.98. This indicates that the market values FENC at -47.98 times its book value.

What is the current FCF Yield for Fennec Pharmaceuticals Inc (FENC) as of Mar 04 2026?

As of Mar 04 2026, Fennec Pharmaceuticals Inc (FENC) has a FCF Yield of -3.04%. This means that for every dollar of Fennec Pharmaceuticals Inc's market capitalization, the company generates -3.04 cents in free cash flow.

What is the current Forward P/E ratio for Fennec Pharmaceuticals Inc (FENC) as of Mar 04 2026?

As of Mar 04 2026, Fennec Pharmaceuticals Inc (FENC) has a Forward P/E ratio of 15.84. This means the market is willing to pay $15.84 for every dollar of Fennec Pharmaceuticals Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Fennec Pharmaceuticals Inc (FENC) as of Mar 04 2026?

As of Mar 04 2026, Fennec Pharmaceuticals Inc (FENC) has a Forward P/S ratio of 3.76. This means the market is valuing FENC at $3.76 for every dollar of expected revenue over the next 12 months.

FENC Valuation